Kevin Fischbeck

In a report published Tuesday, Bank of America analyst Kevin Fischbeck reiterated an Underperform rating on HealthSouth (NYSE: HLS), and raised the price target from $32.00 to $36.00. In the report, Bank of America noted, “Adj EBITDA of $153m was $8m above our est and $14m above consensus. HLS...

In a report published Monday, Bank of America analyst Kevin Fischbeck reiterated a Buy rating on WellCare Health Plans (NYSE: WCG), but lowered the price target from $89.00 to $75.00. In the report, Bank of America noted, “Our Buy rating reflects a view that the company is well positioned to take...

In a report published Friday, Bank of America analyst Kevin Fischbeck reiterated a Buy rating on Universal Health Services (NYSE: UHS), and raised the price target from $106.00 to $113.00. In the report, Bank of America noted, “EPS of $1.51 beat consensus/our est by $0.26 / $0.16 with $0.09 coming...

In a report published Thursday, Bank of America analyst Kevin Fischbeck upgraded the rating on Health Net (NYSE: HNT) from Underperform to Buy, and raised the price target from $33.00 to $59.00. In the report, Bank of America noted, “We are upgrading HNT to Buy (from Underperform) with a view that...

In a report published Wednesday, Bank of America analyst Kevin Fischbeck reiterated a Buy rating on Centene (NYSE: CNC), and raised the price target from $89.00 to $94.00. In the report, Bank of America noted, “CNC reported Q2 EPS of $0.79, $0.07 above consensus and $0.09 above our ests, driven...

In a report published Thursday, Bank of America analyst Kevin Fischbeck reiterated a Buy rating on Envision Healthcare (NYSE: EVHC), and raised the price target from $41.00 to $43.00. In the report, Bank of America noted, “EVHC said it closed the previously announced acquisition of Phoenix...

Improving profits at hospital companies is one likely outcome of the Affordable Care Act, according to an analyst who boosted price targets of a raft of stocks in the sector Tuesday. The biggest ramp-up is expected during the second quarter. Fewer bad debts and charity cases constitute...

In a report published Friday, Bank of America analyst Kevin Fischbeck reiterated a Buy rating on Molina Healthcare (NYSE: MOH), and raised the price target from $42.00 to $44.00. In the report, Bank of America noted, “Q1 continuing ops EPS was $0.10, $0.13 above our est/$0.15 above consensus,...

In a report published Monday, Bank of America analyst Kevin Fischbeck reiterated a Neutral rating on WellPoint (NYSE: WLP), and raised the price target from $106.00 to $110.00. In the report, Bank of America noted, “On Friday, WLP held its Investor Day and increased adjusted EPS guidance to at...

In a report published Friday, Bank of America analyst Kevin Fischbeck reiterated a Buy rating on Acadia Healthcare (NASDAQ: ACHC), and raised the price target from $56.00 to $58.00. In the report, Bank of America noted, “Our rating reflects our view that organic growth through bed additions/...

In a report published Friday, Bank of America analyst Kevin Fischbeck reiterated a Buy rating on Brookdale Senior Living (NYSE: BKD), and raised the price target from $37.00 to $38.00. In the report, Bank of America noted, “BKD beat consensus/our CFFO/share est by $0.08/$0.07 on better margins and...

In a report published Tuesday, Bank of America analyst Kevin Fischbeck initiated coverage on Surgical Care Affiliates (NASDAQ: SCAI) with a Buy rating and $34.00 price target. In the report, Bank of America noted, “We initiate Surgical Care Affiliates (SCAI), one of the largest outpatient surgery...

In a report published Monday, Bank of America analyst Kevin Fischbeck initiated coverage on Envision Healthcare Holdings (NYSE: EVHC) with a Buy rating and $34.00 price target. In the report, Bank of America noted, “We are initiating coverage of Envision (EVHC), the largest provider of medical...

In a report published Friday, Bank of America analyst Kevin Fischbeck upgraded the rating on Aetna (NYSE: AET) from Neutral to Buy, and raised the price target from $68.00 to $79.00. In the report, Bank of America noted, “AET's initial exchange strategy was to target participation in 14 states but...

In a report published Friday, Bank of America analyst Kevin Fischbeck upgraded the rating on WellPoint (NYSE: WLP) from Underperform to Neutral, and raised the price target from $90.00 to $98.00. In the report, Bank of America noted, “As details around the exchanges start to come into view, we now...